TMED4
gene geneOn this page
Also known as HNLFp24alpha3p24a3
Summary
TMED4 (transmembrane p24 trafficking protein 4, HGNC:22301) is a protein-coding gene on chromosome 7p13, encoding Transmembrane emp24 domain-containing protein 4 (Q7Z7H5). Involved in vesicular protein trafficking, mainly in the early secretory pathway. targeting.
Involved in positive regulation of canonical NF-kappaB signal transduction. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in several cellular components, including COPII-coated ER to Golgi transport vesicle; Golgi apparatus; and endoplasmic reticulum-Golgi intermediate compartment.
Source: NCBI Gene 222068 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 32 total
- MANE Select transcript:
NM_182547
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22301 |
| Approved symbol | TMED4 |
| Name | transmembrane p24 trafficking protein 4 |
| Location | 7p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | HNLF, p24alpha3, p24a3 |
| Ensembl gene | ENSG00000158604 |
| Ensembl biotype | protein_coding |
| OMIM | 612038 |
| Entrez | 222068 |
Gene structure
Transcript identifiers
Ensembl transcripts: 6 — 4 protein_coding, 1 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000289577, ENST00000444131, ENST00000457408, ENST00000477639, ENST00000481238, ENST00000947445
RefSeq mRNA: 6 — MANE Select: NM_182547
NM_001303058, NM_001303059, NM_001303060, NM_001303061, NM_001303062, NM_182547
CCDS: CCDS5493, CCDS78226, CCDS78227
Canonical transcript exons
ENST00000457408 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001039816 | 44581723 | 44581823 |
| ENSE00001795091 | 44582047 | 44582231 |
| ENSE00003676999 | 44581093 | 44581239 |
| ENSE00003683759 | 44581449 | 44581574 |
| ENSE00004034842 | 44577894 | 44579628 |
Expression profiles
Bgee: expression breadth ubiquitous, 263 present calls, max score 99.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 56.4738 / max 371.8532, expressed in 1825 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 83889 | 55.1718 | 1825 |
| 83890 | 0.6144 | 361 |
| 83888 | 0.5163 | 281 |
| 83887 | 0.1713 | 99 |
Top tissues by expression
263 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oviduct epithelium | UBERON:0004804 | 99.51 | gold quality |
| kidney epithelium | UBERON:0004819 | 98.80 | gold quality |
| corpus epididymis | UBERON:0004359 | 98.53 | gold quality |
| caput epididymis | UBERON:0004358 | 98.41 | gold quality |
| trachea | UBERON:0003126 | 98.03 | gold quality |
| superior surface of tongue | UBERON:0007371 | 97.82 | gold quality |
| cauda epididymis | UBERON:0004360 | 97.76 | gold quality |
| saphenous vein | UBERON:0007318 | 97.67 | gold quality |
| ileal mucosa | UBERON:0000331 | 97.41 | gold quality |
| duodenum | UBERON:0002114 | 97.35 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 97.19 | gold quality |
| thyroid gland | UBERON:0002046 | 97.15 | gold quality |
| renal medulla | UBERON:0000362 | 97.02 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 96.90 | gold quality |
| fallopian tube | UBERON:0003889 | 96.85 | gold quality |
| tongue | UBERON:0001723 | 96.74 | gold quality |
| cortex of kidney | UBERON:0001225 | 96.67 | gold quality |
| trigeminal ganglion | UBERON:0001675 | 96.48 | gold quality |
| jejunal mucosa | UBERON:0000399 | 96.41 | gold quality |
| adenohypophysis | UBERON:0002196 | 96.38 | gold quality |
| pituitary gland | UBERON:0000007 | 96.36 | gold quality |
| vena cava | UBERON:0004087 | 96.30 | gold quality |
| left ovary | UBERON:0002119 | 96.19 | gold quality |
| body of pancreas | UBERON:0001150 | 96.15 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 96.09 | gold quality |
| metanephros cortex | UBERON:0010533 | 96.05 | gold quality |
| ovary | UBERON:0000992 | 96.01 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 95.98 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 95.91 | gold quality |
| pons | UBERON:0000988 | 95.86 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-7303 | no | 2118.10 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
113 targeting TMED4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4476 | 100.00 | 68.18 | 2030 |
| HSA-MIR-6876-5P | 100.00 | 67.68 | 2126 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4533 | 100.00 | 69.48 | 2758 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-10401-5P | 99.99 | 65.79 | 948 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-4725-3P | 99.96 | 69.53 | 2520 |
| HSA-MIR-6780B-5P | 99.96 | 69.60 | 2562 |
Literature-anchored findings (GeneRIF, showing 1)
- ERS25 may play a critical role in regulation of heat-shock response and apoptosis (PMID:18326488)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmed4 | ENSDARG00000024954 |
| mus_musculus | Tmed4 | ENSMUSG00000004394 |
| rattus_norvegicus | Tmed4 | ENSRNOG00000005016 |
| drosophila_melanogaster | p24-2 | FBGN0053105 |
| drosophila_melanogaster | eca | FBGN0069242 |
| caenorhabditis_elegans | WBGENE00011606 |
Paralogs (8): TMED2 (ENSG00000086598), TMED1 (ENSG00000099203), TMED5 (ENSG00000117500), TMED7 (ENSG00000134970), TMED6 (ENSG00000157315), TMED3 (ENSG00000166557), TMED10 (ENSG00000170348), TMED9 (ENSG00000184840)
Protein
Protein identifiers
Transmembrane emp24 domain-containing protein 4 — Q7Z7H5 (reviewed: Q7Z7H5)
Alternative names: Endoplasmic reticulum stress-response protein 25, GMP25iso, Putative NF-kappa-B-activating protein 156, p24 family protein alpha-3
All UniProt accessions (2): Q7Z7H5, F8W7F7
UniProt curated annotations — full annotation on UniProt →
Function. Involved in vesicular protein trafficking, mainly in the early secretory pathway. targeting. Involved in the maintenance of the Golgi apparatus. Appears to play a role in the biosynthesis of secreted cargo including processing. Involved in endoplasmic reticulum stress response. May play a role in the regulation of heat-shock response and apoptosis.
Subcellular location. Endoplasmic reticulum membrane.
Similarity. Belongs to the EMP24/GP25L family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q7Z7H5-1 | 1 | yes |
| Q7Z7H5-2 | 2 | |
| Q7Z7H5-3 | 3 |
RefSeq proteins (6): NP_001289987, NP_001289988, NP_001289989, NP_001289990, NP_001289991, NP_872353* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009038 | GOLD_dom | Domain |
| IPR015720 | Emp24-like | Family |
Pfam: PF01105
UniProt features (13 total): splice variant 3, topological domain 2, short sequence motif 2, signal peptide 1, chain 1, transmembrane region 1, domain 1, coiled-coil region 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7H5-F1 | 86.02 | 0.51 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 117
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 155 (showing top):
TGCGCANK_UNKNOWN, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION, TGACCTY_ERR1_Q2, GOBP_VESICLE_MEDIATED_TRANSPORT, GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT, GOCC_COATED_VESICLE, HNF4_01, GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION, GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GUO_HEX_TARGETS_DN, BASAKI_YBX1_TARGETS_DN, chr7p13, GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION
GO Biological Process (5): intracellular protein transport (GO:0006886), endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888), Golgi organization (GO:0007030), positive regulation of canonical NF-kappaB signal transduction (GO:0043123), protein transport (GO:0015031)
GO Molecular Function (0):
GO Cellular Component (6): endoplasmic reticulum (GO:0005783), endoplasmic reticulum membrane (GO:0005789), endoplasmic reticulum-Golgi intermediate compartment (GO:0005793), Golgi apparatus (GO:0005794), COPII-coated ER to Golgi transport vesicle (GO:0030134), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoplasm | 4 |
| intracellular membrane-bounded organelle | 3 |
| intracellular protein localization | 2 |
| intracellular transport | 2 |
| endomembrane system | 2 |
| protein transport | 1 |
| intercellular transport | 1 |
| Golgi vesicle transport | 1 |
| organelle organization | 1 |
| endomembrane system organization | 1 |
| canonical NF-kappaB signal transduction | 1 |
| regulation of canonical NF-kappaB signal transduction | 1 |
| positive regulation of intracellular signal transduction | 1 |
| transport | 1 |
| establishment of protein localization | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| coated vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
874 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMED4 | TMED5 | Q9Y3A6 | 689 |
| TMED4 | TMED10 | P49755 | 657 |
| TMED4 | TMED1 | Q13445 | 622 |
| TMED4 | TM9SF3 | Q9HD45 | 481 |
| TMED4 | ACBD3 | Q9H3P7 | 434 |
| TMED4 | SSMEM1 | Q8WWF3 | 421 |
| TMED4 | TMED2 | Q15363 | 420 |
| TMED4 | EMC7 | Q9NPA0 | 411 |
| TMED4 | DYM | Q7RTS9 | 385 |
| TMED4 | RNF212B | A8MTL3 | 371 |
| TMED4 | UFC1 | Q9Y3C8 | 358 |
| TMED4 | IFT74 | Q96LB3 | 358 |
| TMED4 | TMED6 | Q8WW62 | 356 |
| TMED4 | MCFD2 | Q8NI22 | 356 |
| TMED4 | PITPNM1 | O00562 | 353 |
IntAct
95 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GORASP2 | GOLGA2 | psi-mi:“MI:0914”(association) | 0.880 |
| RFX3 | RFX1 | psi-mi:“MI:0914”(association) | 0.730 |
| TMED10 | TMED1 | psi-mi:“MI:0914”(association) | 0.730 |
| TMED9 | TMED10 | psi-mi:“MI:0914”(association) | 0.730 |
| DDRGK1 | UFL1 | psi-mi:“MI:0914”(association) | 0.710 |
| TMED2 | ATP9A | psi-mi:“MI:0914”(association) | 0.640 |
| CHST8 | CANX | psi-mi:“MI:0914”(association) | 0.640 |
| FBXO2 | TMEM131L | psi-mi:“MI:0914”(association) | 0.530 |
| FGF3 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| IL13RA2 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| NUP62 | RGPD8 | psi-mi:“MI:0914”(association) | 0.530 |
| LIPG | NRP1 | psi-mi:“MI:0914”(association) | 0.530 |
| CDK5RAP3 | PLD2 | psi-mi:“MI:0914”(association) | 0.530 |
| HEATR3 | SLC27A2 | psi-mi:“MI:0914”(association) | 0.530 |
| SCN3B | ABCC5 | psi-mi:“MI:0914”(association) | 0.530 |
| TMED3 | HS1BP3 | psi-mi:“MI:0914”(association) | 0.530 |
| rev | TMED10 | psi-mi:“MI:0914”(association) | 0.460 |
| Gorasp1 | CLIP-170 | psi-mi:“MI:0915”(physical association) | 0.400 |
| Dennd6a | IFT88 | psi-mi:“MI:0914”(association) | 0.350 |
| Tmed10 | TARS3 | psi-mi:“MI:0914”(association) | 0.350 |
| Tmed10 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| Tmed2 | psi-mi:“MI:0914”(association) | 0.350 | |
| PDHA1 | psi-mi:“MI:0914”(association) | 0.350 | |
| ENG | IGKV2-28 | psi-mi:“MI:0914”(association) | 0.350 |
| PEBP1 | ANXA2P2 | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| TMEM223 | psi-mi:“MI:0914”(association) | 0.350 | |
| MAPT | SHTN1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (132): TMED4 (Affinity Capture-RNA), TMED4 (Affinity Capture-RNA), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Co-fractionation), TMED4 (Co-fractionation), TMED4 (Co-fractionation), TMED4 (Co-fractionation), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS), TMED4 (Affinity Capture-MS)
ESM2 similar proteins: A0AQ71, B3LVB0, B3P6T8, B4GE47, B4HJV5, B4JYU5, B4K4G5, B4KB41, B4LYB8, B4MGF8, B4NIY1, B4NKL0, B4PUZ3, B4QWH9, F4J4Y0, O13770, O13946, O14324, O35587, O81045, P27869, P32803, P38819, P49755, P53198, Q05359, Q12403, Q12450, Q28735, Q3T133, Q4P958, Q54BN0, Q5E971, Q5I0E7, Q5RE32, Q63584, Q6C503, Q759T8, Q7Z7H5, Q8GYG1
Diamond homologs: A7SXK3, D3ZTX0, O17528, P32803, P49020, Q15363, Q3T133, Q54BN0, Q5I0E7, Q63524, Q6AY25, Q6BTC2, Q769F9, Q78IS1, Q7Z7H5, Q8R1V4, Q99KF1, Q9P7I9, Q9R0Q3, Q9Y3B3, Q9Y3Q3, B3MTS8, B3NZM5, B4GMC3, B4HJV5, B4JG34, B4KB41, B4LYB8, B4NKL0, B4PVC6, B4QWH9, O14324, O35587, P0CN72, P0CN73, P27869, P49755, P53198, Q28735, Q295B2
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 122 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| COPI-dependent Golgi-to-ER retrograde traffic | 7 | 9.7× | 2e-03 |
| COPI-mediated anterograde transport | 7 | 9.6× | 2e-03 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| endoplasmic reticulum to Golgi vesicle-mediated transport | 10 | 13.1× | 4e-06 |
| Golgi organization | 9 | 11.6× | 3e-05 |
| intracellular protein transport | 10 | 6.2× | 1e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
32 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 26 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
427 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:44579480:TA:T | donor_gain | 1.0000 |
| 7:44579624:CGATA:C | acceptor_gain | 1.0000 |
| 7:44579627:TA:T | acceptor_gain | 1.0000 |
| 7:44579629:C:CC | acceptor_gain | 1.0000 |
| 7:44581103:T:TA | donor_gain | 1.0000 |
| 7:44581235:ACCCG:A | acceptor_gain | 1.0000 |
| 7:44581236:CCCG:C | acceptor_gain | 1.0000 |
| 7:44581236:CCCGC:C | acceptor_gain | 1.0000 |
| 7:44581237:CCG:C | acceptor_gain | 1.0000 |
| 7:44581237:CCGC:C | acceptor_gain | 1.0000 |
| 7:44581238:CG:C | acceptor_gain | 1.0000 |
| 7:44581238:CGC:C | acceptor_gain | 1.0000 |
| 7:44581239:GC:G | acceptor_loss | 1.0000 |
| 7:44581240:C:CC | acceptor_gain | 1.0000 |
| 7:44581443:TCTTA:T | donor_loss | 1.0000 |
| 7:44581444:CTTA:C | donor_loss | 1.0000 |
| 7:44581445:TTAC:T | donor_loss | 1.0000 |
| 7:44581446:TAC:T | donor_loss | 1.0000 |
| 7:44581447:A:AC | donor_gain | 1.0000 |
| 7:44581447:ACC:A | donor_loss | 1.0000 |
| 7:44581448:C:CA | donor_loss | 1.0000 |
| 7:44581448:C:CC | donor_gain | 1.0000 |
| 7:44581448:CCAG:C | donor_gain | 1.0000 |
| 7:44581717:CCTTA:C | donor_loss | 1.0000 |
| 7:44581718:CTTAC:C | donor_loss | 1.0000 |
| 7:44581719:TTACC:T | donor_loss | 1.0000 |
| 7:44581720:TA:T | donor_loss | 1.0000 |
| 7:44581721:A:T | donor_loss | 1.0000 |
| 7:44581722:C:CA | donor_loss | 1.0000 |
| 7:44581823:CCTG:C | acceptor_loss | 1.0000 |
AlphaMissense
1488 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:44579624:C:G | R180P | 1.000 |
| 7:44579496:C:G | A223P | 0.999 |
| 7:44579501:A:C | F221C | 0.999 |
| 7:44579503:G:C | F220L | 0.999 |
| 7:44579503:G:T | F220L | 0.999 |
| 7:44579505:A:G | F220L | 0.999 |
| 7:44579513:A:G | L217P | 0.999 |
| 7:44579534:C:T | G210D | 0.999 |
| 7:44579535:C:G | G210R | 0.999 |
| 7:44579546:A:T | L206H | 0.999 |
| 7:44579571:A:G | W198R | 0.999 |
| 7:44579571:A:T | W198R | 0.999 |
| 7:44579599:G:C | S188R | 0.999 |
| 7:44579599:G:T | S188R | 0.999 |
| 7:44579601:T:G | S188R | 0.999 |
| 7:44579609:C:G | R185P | 0.999 |
| 7:44579611:G:C | F184L | 0.999 |
| 7:44579611:G:T | F184L | 0.999 |
| 7:44579613:A:G | F184L | 0.999 |
| 7:44581106:T:G | Q174P | 0.999 |
| 7:44581145:C:G | R161P | 0.999 |
| 7:44581154:A:G | L158P | 0.999 |
| 7:44581196:T:C | Y144C | 0.999 |
| 7:44581229:A:G | L133P | 0.999 |
| 7:44581498:C:G | C113S | 0.999 |
| 7:44581498:C:T | C113Y | 0.999 |
| 7:44581499:A:G | C113R | 0.999 |
| 7:44581499:A:T | C113S | 0.999 |
| 7:44581508:G:C | H110D | 0.999 |
| 7:44581513:C:A | G108V | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000017430 (7:44583714 A>G), RS1000063199 (7:44584130 C>T), RS1000161456 (7:44583226 T>C), RS1000359756 (7:44577813 A>G), RS1001407164 (7:44577424 C>A), RS1001671719 (7:44582704 G>C), RS1001703745 (7:44583087 C>T), RS1002023198 (7:44581571 C>A), RS1002977856 (7:44582166 C>G,T), RS1003684397 (7:44580083 G>T), RS1003736807 (7:44580396 T>G), RS1004138038 (7:44581894 G>T), RS1005808276 (7:44580242 G>A,C), RS1005866149 (7:44579979 A>G), RS1006497063 (7:44583395 C>G,T)
Disease associations
OMIM: gene MIM:612038 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression | 2 |
| entinostat | decreases expression, affects cotreatment | 2 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | decreases expression, affects cotreatment, increases expression | 2 |
| Hydrogen Peroxide | affects cotreatment, increases expression, affects expression | 2 |
| Dronabinol | decreases expression, increases expression | 2 |
| Valproic Acid | increases expression | 2 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression, increases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| tetrahydropalmatine | decreases expression | 1 |
| o,p’-DDT | decreases expression | 1 |
| cupric oxide | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| glycidamide | increases expression | 1 |
| bisphenol B | increases expression | 1 |
| abrine | decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| bisphenol S | increases expression | 1 |
| LDN 193189 | affects cotreatment, increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Temozolomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Diethylstilbestrol | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Ivermectin | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Theophylline | affects cotreatment, increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B3JE | Abcam HEK293T TMED4 KO | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.